FindTrial
Sign In

A trial to compare two dosage schedules of medical abortion in second trimester.

A randomized trial to compare two dosage schedule of misoprostol following mifepristone for midtrimester termination of pregnancy(12-20weeks).

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/05/001770
Enrollment
200
Registered
2011-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Mifepristone , misoprostol in two different schedule.: Group1 will receive 200mg of mifepristone followed by 800 microgram misoprostol after 48 hoursfol,then 400 microgram 3hrly for 4 d

Sponsors

NRS Medical CollegeKolkata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women opting for abortion during 12-20 weeks

Exclusion criteria

Exclusion criteria: Known hypersensitivity to mifepristone,misoprostol Scarred uterus Low lying placenta Hb less than 8 gm% Serious medical Diseases Features of Inevitable abortion.

Design outcomes

Primary

MeasureTime frame
Rate of successful abortion,induction to abortion interval.Timepoint: 12-20weeks—

Secondary

MeasureTime frame
Additional intervention,side effects, complications,Acceptability.Timepoint: 24 hours after the last dose of misoprostol.—

Countries

India

Contacts

Public ContactDr Picklu Chaudhuri

NRS medical College,Kolkata.

picklu.chaudhuri@gmail.com033-25797827

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 10, 2026